Suzanne Oparil

472 total citations
14 papers, 348 citations indexed

About

Suzanne Oparil is a scholar working on Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems and Physiology. According to data from OpenAlex, Suzanne Oparil has authored 14 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Endocrine and Autonomic Systems and 2 papers in Physiology. Recurrent topics in Suzanne Oparil's work include Blood Pressure and Hypertension Studies (5 papers), Heart Failure Treatment and Management (4 papers) and Renin-Angiotensin System Studies (4 papers). Suzanne Oparil is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Heart Failure Treatment and Management (4 papers) and Renin-Angiotensin System Studies (4 papers). Suzanne Oparil collaborates with scholars based in United States. Suzanne Oparil's co-authors include Allen Hester, S.C. Dyke, David A. Calhoun, Qing Cheng Meng, J. Michael Wyss, Renhui Yang, H. Jin, Jin He, Yiu-Fai Chen and Y F Chen and has published in prestigious journals such as JAMA, Brain Research and Hypertension.

In The Last Decade

Suzanne Oparil

13 papers receiving 328 citations

Peers

Suzanne Oparil

CCM

EDM

MB

ND

SURGE

Fritz R. B hler Switzerland

Shaler G. Smith United States

G. Schröder Sweden

Kunio Kurata Japan

Ana M. Puyó Argentina

R E McCaa Guatemala

Andrew Leary Ireland

R. W. Sevy United States

Keiko Nishi Japan

L. Poletti Italy

Fritz R. B hler Switzerland

Suzanne Oparil

198 ×0.8

CCM

66 ×0.6

EDM

68 ×0.9

MB

25 ×0.6

ND

25 ×0.7

SURGE

Citations per year, relative to Suzanne Oparil Suzanne Oparil (= 1×) peers Fritz R. B hler

Countries citing papers authored by Suzanne Oparil

Since Specialization

Citations

This map shows the geographic impact of Suzanne Oparil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Oparil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Oparil more than expected).

Fields of papers citing papers by Suzanne Oparil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Oparil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Oparil. The network helps show where Suzanne Oparil may publish in the future.

Co-authorship network of co-authors of Suzanne Oparil

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Oparil. A scholar is included among the top collaborators of Suzanne Oparil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Oparil. Suzanne Oparil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Oparil, Suzanne. (2002). Are there meaningful differences in blood pressure control with current antihypertensive agents?. American Journal of Hypertension. 15(1). S14–S21. 12 indexed citations

2.

Oparil, Suzanne. (2000). Newly emerging pharmacologic differences in angiotensin II receptor blockers. American Journal of Hypertension. 13(1). S18–S24. 74 indexed citations

3.

Oparil, Suzanne. (1999). Management of the hypertensive patient with coronary artery disease. American Journal of Hypertension. 12(2). 56S–62S. 4 indexed citations

4.

Oparil, Suzanne. (1998). Mibefradil, a T-Channel?Selective Calcium AntagonistClinical Trials in Hypertension. American Journal of Hypertension. 11(4). 88S–94S. 7 indexed citations

5.

Oparil, Suzanne. (1998). E101 Candesartan cilexetil enhances blood pressure reduction in severe (stage 3, JNC-VI) hypertensive patients inadequately controlled with HCTZ. American Journal of Hypertension. 11(4). 121A–121A. 4 indexed citations

6.

Oparil, Suzanne. (1997). A 42-Year-Old Man With Hypertension. JAMA. 278(12). 1015–1015.

7.

Meng, Qing Cheng & Suzanne Oparil. (1996). Purification and assay methods for angiotensin-converting enzyme. Journal of Chromatography A. 743(1). 105–122. 25 indexed citations

8.

Oparil, Suzanne, et al.. (1996). The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clinical Therapeutics. 18(5). 797–810. 128 indexed citations

9.

Calhoun, David A. & Suzanne Oparil. (1995). Racial Differences in the Pathogenesis of Hypertension. The American Journal of the Medical Sciences. 310. S86–S90. 28 indexed citations

10.

Yang, Renhui, H. Jin, J. Michael Wyss, & Suzanne Oparil. (1992). Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.. Hypertension. 19(5). 475–481. 41 indexed citations

11.

Chen, Yiu-Fai, et al.. (1991). Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake. Brain Research. 565(1). 135–141. 11 indexed citations

12.

He, Jin, Y F Chen, Renhui Yang, & Suzanne Oparil. (1989). Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats.. Hypertension. 14(4). 404–412. 8 indexed citations

13.

Wallace, Kendall B., Suzanne Oparil, & M. D. Bailie. (1981). Angiotensin II Metabolism by Tissues from Developing Rats. Pediatric Research. 15(8). 1088–1092. 2 indexed citations

14.

Oparil, Suzanne. (1978). Hypertension and oral contraceptives.. BMJ. 1(6127). 1570.2–1571. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact